Skip to main content
Erschienen in: Pediatric Cardiology 3/2020

20.03.2020 | Review Article

Regulatory Science, and How Device Regulation Will Shape Our Future

verfasst von: Nicole Ibrahim, Nicole Gillette, Hetal Patel, Vasum Peiris

Erschienen in: Pediatric Cardiology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Pediatric medical device approvals lag behind adult approvals. Historically, medical devices have rarely been designed specifically for children, but use in children has most often borrowed from adult or general use applications. While a variety of social, economic, and clinical factors have contributed to this phenomenon, the regulatory process remains a fundamental aspect of pediatric device development and commercialization. FDA’s Center for Devices and Radiological Health (CDRH) has established programmatic and technological areas of advancement to support innovation that serves the public health needs of children and special populations. We highlight four regulatory areas that have the potential to shape the future of pediatric cardiology: the CDRH Early Feasibility Study Program, advancements in 3D printing or additive manufacturing, computational modeling and simulation, and the use of real-world evidence for regulatory applications. These programs have the potential to impact all stages of device development, from early conception, design, and prototyping to clinical evidence generation, regulatory review, and finally commercialization. The success of these programs relies on a collaborative community of stakeholders, including government, regulators, device manufacturers, patients, payers, and the academic and professional community societies.
Literatur
1.
Zurück zum Zitat Rontgen W (1896) On a new kind of rays. Nature 53:274–276 Rontgen W (1896) On a new kind of rays. Nature 53:274–276
2.
Zurück zum Zitat Williams F (1896) A method for more fully determining the outlines of the heart by means of a fluoroscope. Boston Med Surg 135:335–337CrossRef Williams F (1896) A method for more fully determining the outlines of the heart by means of a fluoroscope. Boston Med Surg 135:335–337CrossRef
3.
Zurück zum Zitat Einthoven W (1906) Le telecardiogramme. Arch Inst Physiol 4:132–164 Einthoven W (1906) Le telecardiogramme. Arch Inst Physiol 4:132–164
4.
Zurück zum Zitat Gross R, Hubbard J (1939) Surgical ligation of a patent ductus arteriosus: report of first successful case. JAMA 112:729–731CrossRef Gross R, Hubbard J (1939) Surgical ligation of a patent ductus arteriosus: report of first successful case. JAMA 112:729–731CrossRef
5.
Zurück zum Zitat Gibbon J (1954) Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 37:171–185PubMed Gibbon J (1954) Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 37:171–185PubMed
6.
Zurück zum Zitat Kirklin J, Dushane J, Patrick R, Donald D, Hetzel P, Harshbarger H, Wood H (1955) Intracardiac surgery with the aid of a mechanical pumpoxygenator system (gibbon type): report of eight cases. Mayo Clin Proc 201–206 Kirklin J, Dushane J, Patrick R, Donald D, Hetzel P, Harshbarger H, Wood H (1955) Intracardiac surgery with the aid of a mechanical pumpoxygenator system (gibbon type): report of eight cases. Mayo Clin Proc 201–206
7.
Zurück zum Zitat Lillehei C, Cohen M, Warden H, Varco R (1955) The direct vision intracardiac correction of congenital anomalies by controlled cross circulation. Results in thirty two patients with ventricular septal defects, tetrology of Fallot, and atrioventricular communis defects. Surgery 30:11–29 Lillehei C, Cohen M, Warden H, Varco R (1955) The direct vision intracardiac correction of congenital anomalies by controlled cross circulation. Results in thirty two patients with ventricular septal defects, tetrology of Fallot, and atrioventricular communis defects. Surgery 30:11–29
8.
Zurück zum Zitat Forssmann W (1929) Sonderung des rechter. Herzenz Kein Wochenschr 28:2085–2087CrossRef Forssmann W (1929) Sonderung des rechter. Herzenz Kein Wochenschr 28:2085–2087CrossRef
9.
Zurück zum Zitat Cournand A, Baldwin J, Himmelstein A (1949) Cardiac catherization in congenital heart disease: a clinical and physiological study in infants and children. Commonwealth Fund, New York Cournand A, Baldwin J, Himmelstein A (1949) Cardiac catherization in congenital heart disease: a clinical and physiological study in infants and children. Commonwealth Fund, New York
10.
Zurück zum Zitat Martin J, Hamilton B, Osterman M (2017) Births in the United States, 2016. NCHS Data Brief, pp 1–8 Martin J, Hamilton B, Osterman M (2017) Births in the United States, 2016. NCHS Data Brief, pp 1–8
11.
Zurück zum Zitat Workshop P (2017) Advancing the development of pediatric therapeutics (ADEPT): application of "Big Data" to pediatric safety studies. Food and Drug Administration, Silver Spring Workshop P (2017) Advancing the development of pediatric therapeutics (ADEPT): application of "Big Data" to pediatric safety studies. Food and Drug Administration, Silver Spring
12.
Zurück zum Zitat Workshop P (2010) Developing pathways to market for pediatric heart valves. Food and Drug Administration, AdvaMed, Silver Spring Workshop P (2010) Developing pathways to market for pediatric heart valves. Food and Drug Administration, AdvaMed, Silver Spring
13.
Zurück zum Zitat Workshop P (2016) Pediatric clinical investigator training. Food and Drug Administration, Silver Spring Workshop P (2016) Pediatric clinical investigator training. Food and Drug Administration, Silver Spring
14.
Zurück zum Zitat Workshop P (2018) Pediatric medical device development. Food and Drug Administration, Silver Spring Workshop P (2018) Pediatric medical device development. Food and Drug Administration, Silver Spring
15.
Zurück zum Zitat Workshop P (2017) Pediatric trial design and modeling: moving into the next decade. Food and Drug Administration, Silver Spring Workshop P (2017) Pediatric trial design and modeling: moving into the next decade. Food and Drug Administration, Silver Spring
16.
Zurück zum Zitat Breakthrough Devices Program: Guidance for Industry and Food and Drug Administration Staff (2018) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research, Silver Spring Breakthrough Devices Program: Guidance for Industry and Food and Drug Administration Staff (2018) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research, Silver Spring
17.
Zurück zum Zitat Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices (2016) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research, Silver Spring Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices (2016) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research, Silver Spring
18.
Zurück zum Zitat Investigational Device Exemptions (IDEs) for Early Feasibility Medical Device Clinical Studies, Including Certain First in Human (FIH) Studies (2013) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research., Silver Spring Investigational Device Exemptions (IDEs) for Early Feasibility Medical Device Clinical Studies, Including Certain First in Human (FIH) Studies (2013) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research., Silver Spring
19.
Zurück zum Zitat Holmes D, Califf R, Farb A, Abel D, Mack M, Syrek Jensen T, Zuckerman B, Leon M, Shuren S (2016) Overcoming the challenges of conducting early feasibility studies of medical devices in the United States. JACC 68:1908–1915 Holmes D, Califf R, Farb A, Abel D, Mack M, Syrek Jensen T, Zuckerman B, Leon M, Shuren S (2016) Overcoming the challenges of conducting early feasibility studies of medical devices in the United States. JACC 68:1908–1915
20.
Zurück zum Zitat Technical Considerations for Additive Manufactured Medical Devices: Guidance for Industry and Food and Drug Administration Staff (2017) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research, Silver Spring Technical Considerations for Additive Manufactured Medical Devices: Guidance for Industry and Food and Drug Administration Staff (2017) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research, Silver Spring
21.
Zurück zum Zitat Morrison T, Dreher M, Nagaraja S, Angelone L, Kainz W (2017) The role of computational modeling and simulation in the total product life cycle of peripheral vascular devices. J Med Device 11:024503CrossRef Morrison T, Dreher M, Nagaraja S, Angelone L, Kainz W (2017) The role of computational modeling and simulation in the total product life cycle of peripheral vascular devices. J Med Device 11:024503CrossRef
22.
Zurück zum Zitat Reporting of Computational Modeling Studies in Medical Device Submissions: Guidance for Industry and Food and Drug Administration Staff (2016) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Silver Spring Reporting of Computational Modeling Studies in Medical Device Submissions: Guidance for Industry and Food and Drug Administration Staff (2016) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Silver Spring
23.
Zurück zum Zitat Haddad T, Himes A, Thompson L, Irony T, Nair R (2017) Participants, Incorporation of stochiastic engineering models as prior information in Bayesian medical device trials. J Biopharm Stat 27:1089–1103 Haddad T, Himes A, Thompson L, Irony T, Nair R (2017) Participants, Incorporation of stochiastic engineering models as prior information in Bayesian medical device trials. J Biopharm Stat 27:1089–1103
24.
Zurück zum Zitat Medical Device Classification Procedures: Determination of Safety and Effectiveness (2018) Medical Device Classification Procedures: Determination of Safety and Effectiveness (2018)
25.
Zurück zum Zitat Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices (2017) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research, Silver Spring Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices (2017) U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation Research, Silver Spring
26.
Zurück zum Zitat Dubin A, Cannon B, Saarel E, Triedman J, Berul C, Bar-Cohen Y, Shah M, Paulsen J, Patel H, Reich J, Carlson M, Stein K, Gilkerson J, Kowal R, Peiris V (2019) Pediatric and congential electrophysiology society initiative on device needs in pediatric electrophysiology. Heart Rhythm 16(4):e39–e46CrossRef Dubin A, Cannon B, Saarel E, Triedman J, Berul C, Bar-Cohen Y, Shah M, Paulsen J, Patel H, Reich J, Carlson M, Stein K, Gilkerson J, Kowal R, Peiris V (2019) Pediatric and congential electrophysiology society initiative on device needs in pediatric electrophysiology. Heart Rhythm 16(4):e39–e46CrossRef
Metadaten
Titel
Regulatory Science, and How Device Regulation Will Shape Our Future
verfasst von
Nicole Ibrahim
Nicole Gillette
Hetal Patel
Vasum Peiris
Publikationsdatum
20.03.2020
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 3/2020
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-020-02296-0

Weitere Artikel der Ausgabe 3/2020

Pediatric Cardiology 3/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.